| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |